Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010.

Shallcross LJ, Petersen I, Rosenthal J, Johnson AM, Freemantle N, Hayward AC.

Emerg Infect Dis. 2013 Oct;19(10):1646-8. doi: 10.3201/eid1910.130433.

2.

Fusidic acid cream for impetigo. Resistance trends must be monitored.

Zadik P, Young N.

BMJ. 2002 Jun 8;324(7350):1394. No abstract available.

PMID:
12053930
3.

[An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].

Rørtveit S, Rørtveit G.

Tidsskr Nor Laegeforen. 2003 Sep 25;123(18):2557-60. Norwegian.

4.

The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.

Rørtveit S, Skutlaberg DH, Langeland N, Rortveit G.

Scand J Infect Dis. 2014 Dec;46(12):832-7. doi: 10.3109/00365548.2014.947317. Epub 2014 Sep 17.

5.

Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.

Rørtveit S, Rortveit G.

Br J Dermatol. 2007 Jul;157(1):100-5. Epub 2007 Jun 6.

PMID:
17553056
6.

Fusidic acid cream for impetigo. Fusidic acid should be used with restraint.

Brown EM, Wise R.

BMJ. 2002 Jun 8;324(7350):1394. No abstract available.

7.

Fusidic acid cream for impetigo. Judicious use is advisable.

Sule O, Brown N, Brown DF, Burrows N.

BMJ. 2002 Jun 8;324(7350):1394. No abstract available.

PMID:
12053927
8.

Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial.

Koning S, van Suijlekom-Smit LW, Nouwen JL, Verduin CM, Bernsen RM, Oranje AP, Thomas S, van der Wouden JC.

BMJ. 2002 Jan 26;324(7331):203-6.

9.

Fusidic acid cream for impetigo. Findings cannot be extrapolated.

Owen SE, Cheesbrough JS.

BMJ. 2002 Jun 8;324(7350):1394. No abstract available.

PMID:
12053931
10.

Fusidic acid cream for impetigo. Problem may be clinically important.

Stoddart B, Collyns T, Denton M.

BMJ. 2002 Jun 8;324(7350):1394. No abstract available.

PMID:
12053929
11.

Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use.

Weston VC, Boswell TC, Finch RG, Perkins W.

BMJ. 2002 Jun 8;324(7350):1394. No abstract available.

PMID:
12053928
12.

Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.

Alsterholm M, Flytström I, Bergbrant IM, Faergemann J.

Acta Derm Venereol. 2010;90(1):52-7. doi: 10.2340/00015555-0771.

13.

Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.

Vogel A, Lennon D, Best E, Leversha A.

N Z Med J. 2016 Oct 14;129(1443):77-83.

PMID:
27736855
14.

Current options for the treatment of impetigo in children.

Sladden MJ, Johnston GA.

Expert Opin Pharmacother. 2005 Oct;6(13):2245-56. Review.

PMID:
16218885
15.
16.

Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.

Rijnders MI, Wolffs PF, Hopstaken RM, den Heyer M, Bruggeman CA, Stobberingh EE.

J Antimicrob Chemother. 2012 May;67(5):1176-80. doi: 10.1093/jac/dkr590. Epub 2012 Jan 30.

PMID:
22290345
17.

Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid.

Osterlund A, Eden T, Olsson-Liljequist B, Haeggman S, Kahlmeter G; Swedish Study Group on Fusidic Acid-resistant Staphylococcus aureus.

Scand J Infect Dis. 2002;34(10):729-34.

PMID:
12477322
18.

Sensitivity of antibacterials of Staphylococcus aureus isolated from impetigo patients.

Nishijima S, Nakagawa M.

J Int Med Res. 1997 Jul-Aug;25(4):210-3.

PMID:
9283995
19.

[Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study].

Couppié P, Sainte-Marie D, Prévost G, Gravet A, Clyti E, Moreau B, Monteil H, Pradinaud R.

Ann Dermatol Venereol. 1998 Oct;125(10):688-93. French.

PMID:
9835957
20.

Impetigo: incidence and treatment in Dutch general practice in 1987 and 2001--results from two national surveys.

Koning S, Mohammedamin RS, van der Wouden JC, van Suijlekom-Smit LW, Schellevis FG, Thomas S.

Br J Dermatol. 2006 Feb;154(2):239-43.

PMID:
16433791

Supplemental Content

Support Center